Introduction
After knowing the HIV reactive status, most of the people in rural setup choose the native drugs before starting the anti-retroviral therapy (ART), because of the discrimination, false claims by the alternative medical practitioners and the myths about the disease which may have an impact on mutations of the reverse transcriptase (RT) gene. So, it was decided to assess the prevalence of genotypic variations and resistance mutations of the RT gene of HIV, after the native drug pressure among ART naïve rural people living with HIV/AIDS (PLHA).
Materials and Methods

Study design and study population
A total of 40 PLHA who were exposed for indigenous medicines such as Siddha, Ayurveda, etc., for a minimum
Results
Among all (n = 40) isolates, only 36 (20 males, 16 females) were successfully amplified at RT region of pol gene. There were major mutations found that were directly associated with high-level resistance to ARV drugs and the overall prevalence of this was 5.55% (n = 2) against nucleoside RT inhibitor (NRTI) and Non-NRTI (NNRTI). One of the isolates was found to harbour mutations (M184V, T215Y, K103S and G190A) associated with reduced susceptibility to NRTI drugs. The other isolate was found to harbour 2 mutations (K103KN and G190AG) associated with reduced susceptibility to NNRTI drugs. In the RT region, the predominant polymorphisms detected were K122E (91.7%), V60I (91.7%), V35T (89%), Q207E (89%), D177E (89%), T200A (86.1%), S48T (83.33%), K173A (80.6%).
Discussion
Testing for the presence of drug resistance strains prior to initiation of therapy may be economical and beneficial to the individual. [2] In countries where the standard initial and alternate antiretroviral regimens are restricted, it is important to evaluate if transmitted resistance has reached a population level that could affect the effectiveness of ART. Studies from India have not revealed any high prevalence of drug resistance conferring mutation. [3] [4] [5] As per WHO protocol, the drug resistance prevalence in a geographical area can be categorised into three categories <5%, 5-15% and >15%. [6] In the current study, RT regions from the pol gene of HIV-1 viral strains from PLHA were characterised. All pol sequences of the study patients clustered with subtype C reference sequences with no evidence of recombination.
A study by Deshpande et al. from Mumbai indicated that two isolates of 128 (1.6%) had the M184V mutation, indicating primary drug resistance to 3TC. [7] A phenotypic study by Hira et al. conducted in Mumbai has shown a higher prevalence (6.7%) of primary drug resistance to RT inhibitors. [8] Another genotypic study by Balakrishnan et al. from Chennai involving drug naïve patients attending HIV clinic has also shown the absence of primary drug resistance. [9] Our study showed 5.55% prevalence for Primary NNRTI drug resistance and 2.77% to Primary NRTI drug resistance. There was not much variation found in drug resistance compared to the alert cut-off level because of the native drugs used by the ART naïve reactive patients. This study, although limited to 40 drug-naive individuals, offers some reassurance that the contemporary subtype C viruses in Southern India are not likely to exhibit high levels of drug resistance. This is consistent with evidence from other non-subtype B studies.
Enormous polymorphic substitutions were observed in the current study. V35T, K122E, S48T, V60I, T200A, Q207E, D177E, K173A were observed in more than 80% of the sequences. In Iqbal et al., at RT region, the predominant polymorphisms detected were V60I (98.2%), S48T (94.5%), K122E (90.9%), T200A (85.5%), and D177E (80%). [1] These observations reveal that HIV-1 polymorphisms differ in different geographical locations and population groups within the same subtype. These polymorphic variations are important in terms of vaccine design.
Conclusion
In the current study, RT regions from the pol gene of HIV-1 viral strains from PLHA were characterised. HIV-1 drug resistance has been observed among ART-naive PLHA. There was not much variation found in drug resistance compared to the alert cut-off level because of the native drugs used by the ART naïve reactive patients. The presence of drug resistance mutations, though minimal, is important as the drug-resistant strains could spread among PLHA and to their sexual partners. Enormous polymorphic substitutions were observed in the current study. There is a definite need to generate the drug resistance database and the polymorphic pattern of Indian strains for the future clinical management and vaccine design to contain the disease.
